Artificial organ market worth expected to double in the next 5 years

The artificial organ market is expected to more than double by 2022, according to a market analysis report from Yole Développement in France. The market is expected to be work $1.3B in 2017 and with a consumer annual growth rate (CAGR) of 20%, it is expected to be work $3.5B by 2022. “This impressive growth

Medtech stories we missed this week: Nov. 17, 2017

From Skyline Medical’s joint venture to Lensar receiving FDA clearance and CE Mark, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Skyline Medical launches JV deal with Helomics Skyline Medical announced in a Nov. 15 press release that it has signed a joint venture agreement with Helomics.

Chesapeake IRB, Schulman IRB merge to form Advarra

Chesapeake IRB and Schulman IRB have merged to form Advarra, a new provider of IRB, institutional biosafety committee (IBC) and research compliance services. “By coming together as Advarra, we are merging the highest quality review organizations in the industry,” Jeffrey Wendel, president and CEO of Chesapeake IRB said. “Through a customer-centric integration, we will be

This nerve-blocking treatment could treat asthma and heart failure

Electrical nerve-blocking implants could help treat asthma and heart failure, according to new research from Case Western Reserve University. Niloy Bhadra and Kevin Kilgore, professors of biomedical engineering and orthopedic surgery respectively, have been working on the nerve-blocking research since 2000. The research blocks unwanted generation of nerve impulses in a variety of clinical applications.

Less than half of healthcare professionals think medtech brands meet needs

Roughly two-fifths of healthcare professionals say medical device brands aren’t meeting expectations, and failure to offer flexible contract options is also a problem, according to a new survey from Vennli (South Bend, Ind.). The survey, called “Differentiating to Win in Medical Device Marketing,” polled over 9,000 physicians, dentists and other clinicians to figure out what

How a smartphone app can detect concussions on the sidelines

A new app from the University of Washington could screen for concussions and other traumatic brain injuries from a smartphone. Researchers at the University of Washington are currently working to develop a smartphone app that can detect brain injuries when they happen. The app’s goal is to detect the injuries on the sidelines of sports

Non-invasive cell probing offers new insight into disease progression

Massachusetts Institute of Technology engineers have figured out a way to assess the mechanical properties of a cell using simple observation. Usually, cells have to be probed with expensive instruments like atomic force microscopes and optical tweezers to determine the mechanical properties of a cell. Those methods make direct and invasive contact with the cells. The

Medpace announces $60M stock repurchase agreement

Medpace Holdings (Nasdaq: MEDP) is spending about $60.5 million to repurchase stock. The stock repurchase agreement with Cinven Capital Management (V) General Partner Limited, announced yesterday, involves Medpace repurchasing 2 million shares of stock at a price of $30.27 per share. The transaction is expected to close tomorrow, subject to customary closing conditions. The company’s stock

3D printed living tissue may eliminate animal testing

English scientists have figured out a way to 3D print cells grown in a laboratory to create living structures. Researchers at the University of Oxford and the Center for Molecular Medicine at Bristol were able to showcase how human and animal cells could be printed into high-resolution tissue constructs. Being able to control the position

Magnetic fields can destroy biofilms on implants: Here’s how

Alternating magnetic fields may be the key to fighting bacteria that grows on artificial joints, according to new research from the University of Texas Southwestern. Researchers at UT Southwestern claim that short exposure to high-frequency alternating magnetic fields (AMF) has the potential to destroy bacteria that ends up in biofilms growing on the surface of

How a common hospital tool predicts poor outcomes after liver transplants

A frequently used tool in the hospital can be an indicator of which liver transplant recipients will do poorly after surgery, according to new research from Cedars-Sinai Medical Center. Led by Vinay Sundaram, a team of researchers found that the nursing assessment called the Braden Scale could be put to use in liver transplant patients

Medtech stories we missed this week: August 11, 2017

From Xtant Medical’s 510(k) extension to Varian Medical’s distribution deal, here are seven medtech stories we missed this week but thought were still worth a mention. 1. FDA extends Xtant Medical’s 510(k) for Calix C spinal implant Xtant Medical announced in an Aug. 9 press release that the FDA has cleared its product line extensions

This 3D printed implant replaces skull bone

A New Jersey doctor turned to Johnson & Johnson’s DePuy Synthes and a 3D printed implant to replace missing skull bone in a patient. The procedure was performed after the patient suffered brain swelling and the skull became infected. Dr. Gaurav Gupta, assistant professor of neurosurgery at Rutgers Robert Wood Johnson Medical School, had to

Could crystal-based electronics enable medtech innovation?

New crystal-based electronics – in which a laser etches electronic circuitry into a crystal – could enable better electrical interfaces between implantable medical devices and biological tissue, according to the lead researcher behind the technology. “Electrical conductivity affects how cells adhere to a substrate. By optically defining highly conductive regions on the crystal, cells could

How WiFi could monitor sleep disorders

Monitoring sleep disorders could be as easy as measuring the radio waves around a patient through WiFi, according to new research from Massachusetts Institute of Technology and Massachusetts General Hospital. Traditionally, physicians measure sleep disorders through electrodes or other sensors attached to a patient. The new method, however, is a device that uses an advanced